文献速递肺结节与肺癌

机器人辅助与视频辅助肺叶切除术后非小细胞肺癌患者健康相关生活质量:RVlob随机临床试验结果

Health-Related Quality of Life Following Robotic-Assisted or Video-Assisted Lobectomy in Patients With Non-Small Cell Lung Cancer: Results From the RVlob Randomized Clinical Trial.
PubMed 文献 · Chest · 2023-01-05

RVlob单中心开放标签随机临床试验纳入320例可切除非小细胞肺癌患者,比较机器人辅助肺叶切除(RAL)与视频辅助肺叶切除(VAL)术后健康相关生活质量。结果显示两组术后48周内生活质量与疼痛总体相当,仅RAL组第4周平均疼痛评分略低。

要点

  • RAL与VAL术后48周内健康相关生活质量总体相当。
  • RAL组第4周平均疼痛评分略低于VAL组。
  • 两种术式术后疼痛与生活质量均可接受。

核心结论

  • RAL与VAL术后48周内健康相关生活质量与术后疼痛总体相当且满意,仅第4周存在轻微统计学差异。

研究设计与样本

  • 单中心、开放标签随机临床试验,2017年5月至2020年5月纳入320例可切除非小细胞肺癌患者行RAL或VAL(RVlob试验,NCT03134534)。

主要发现

  • RAL组第4周平均疼痛评分显著低于VAL组(2.097 ± 0.111 vs 2.431 ± 0.108;P = .032)。
  • 术后48周内QLQ-C30与QLQ-LC13汇总评分两组相似(P > .05)。
  • EQ-5D评估的健康相关生活质量评分在整个研究期间两组相当(P > .05)。

关键数值与推荐

  • 术后第1天及第4、24、48周采用视觉模拟评分或数字评分评估疼痛。
  • 术后第4、24、48周填写EORTC QLQ-C30、QLQ-LC13与EQ-5D问卷。

临床怎么用

  • 对于可切除非小细胞肺癌,RAL与VAL均可作为可选术式,术后生活质量预期总体相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robot-assisted lobectomy (RAL) is increasingly used as an alternative to video-assisted lobectomy (VAL) for resectable non-small cell lung cancer (NSCLC). However, there is little evidence of any difference in postoperative health-related quality of life (HRQoL) between these two approaches. RESEARCH QUESTION: Is RAL superior to VAL in improving quality of life in patients with resectable NSCLC? STUDY DESIGN AND METHODS: We performed a single-center, open-label randomized clinical trial from May 2017 to May 2020 with 320 enrolled patients undergoing RAL or VAL for resectable NSCLC (RVlob trial; NCT03134534). Postoperative pain was evaluated by visual analog score or numeric rating score on postoperative day 1 and at weeks 4, 24, and 48. The European Organization for Research and Treatment of Cancer (EORTC) Core Quality of Life Questionnaire (QLQ-C30), EORTC Quality of Life Questionnaire in Lung Cancer (QLQ-LC13), and the European Quality of Life 5 Dimensions (EQ-5D) questionnaire were also administered at weeks 4, 24, and 48 after surgery. RESULTS: One hundred and fifty-seven patients underwent RAL and 163 underwent VAL. The mean pain score of patients after RAL was significantly lower at week 4 (2.097 ± 0.111 vs 2.431 ± 0.108; P = .032). QLQ-C30 and QLQ-LC13 summary scores (P > .05) were similar for both RAL and VAL during the first 48 weeks of follow-up. HRQoL scores assessed with the EQ-5D questionnaire were also comparable between the two groups (P > .05) during the whole study period. INTERPRETATION: Both RAL and VAL showed satisfactory and comparable HRQoL and postoperative pain up to 48 weeks after surgery, despite some minor statistical differences at week 4. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT03134534; URL: www. CLINICALTRIALS: gov.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Jin R, Zhang Z, Zheng Y, et al. Health-Related Quality of Life Following Robotic-Assisted or Video-Assisted Lobectomy in Patients With Non-Small Cell Lung Cancer: Results From the RVlob Randomized Clinical Trial. Chest. 2023. PMID: 36621757. doi:10.1016/j.chest.2022.12.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。